Synapharm Industrial Synthesis SA
1.7 FTESynapharm Industrial Synthesis reported total assets of €6.06m at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jul 2026), with 1.7 full-time equivalent.
The score of Synapharm Industrial Synthesis shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +407 % Total assets +304 % Headcount (avg FTE) -6 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Synapharm Industrial Synthesis's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jul 2026
- Year ended 31 Dec 2024filed on 12 Jun 2025
- Year ended 31 Dec 2023filed on 24 Jul 2024
- Year ended 31 Dec 2022filed on 12 Jul 2023
- Year ended 31 Dec 2021filed on 26 Jul 2022
Synapharm Industrial Synthesis's financial analysis
- Solvency61.1%sector median: 66.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Synapharm Industrial Synthesis
7 active director(s) in the register.
and 1 more
Synapharm Industrial Synthesis's shareholders and holdings →Synapharm Industrial Synthesis's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0465.726.791
- VAT number
- BE0465726791
- Peppol
- Registered · 0208:0465726791 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 26 Mar 1999
- Registered office
- 4460 Grâce-Hollogne
- Size
- Micro · 1.7 FTE
- Latest accounts
- 2025 · filed on 17 Jul 2026
- Activity
- Manufacture of other organic basic chemicals (NACE 20140)
Synapharm Industrial Synthesis (SA) has been based in Grâce-Hollogne since 1999, active in: manufacture of other organic basic chemicals. For 2025, it reports a net profit of €1.87m and equity of €3.71m; its revenue is not published. With 1.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 61.1%, below the median of its sector (66.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Synapharm Industrial Synthesis
Companies in the same business, of comparable size and area, outside its group.
- Maco - Pharma Benelux Manufacture of pharmaceutical preparations Mouscron · balance sheet €4.19m
- Laboratoires Lohmann & Rauscher Manufacture of pharmaceutical preparations Liège · balance sheet €4.03m
- Dermax Wholesale of pharmaceutical and medical goods Liège · balance sheet €5.73m
- Surveal Pharma Wholesale of pharmaceutical and medical goods Ixelles · balance sheet €5.47m
- Bio -X Diagnostics Wholesale of pharmaceutical and medical goods Rochefort · balance sheet €5.18m
- Arseus Lab Wholesale of pharmaceutical and medical goods Waregem · balance sheet €6.16m
- Top Class Products & Services Wholesale of pharmaceutical and medical goods Aarschot · balance sheet €5.68m
- LDI International Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €5.71m
Frequently asked questions about Synapharm Industrial Synthesis
What is the revenue of Synapharm Industrial Synthesis?
Synapharm Industrial Synthesis files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Synapharm Industrial Synthesis?
In Belgium, the VAT number is the company number prefixed with BE: BE0465726791 for Synapharm Industrial Synthesis, if the company is VAT-registered. Its company number (CBE) is 0465.726.791.
Where is the registered office of Synapharm Industrial Synthesis?
According to the CBE register, the registered office of Synapharm Industrial Synthesis is in 4460 Grâce-Hollogne.
What is the equity of Synapharm Industrial Synthesis?
At the close of the 2025 financial year, the equity of Synapharm Industrial Synthesis amounts to 3,706,784 €, a solvency of 61.1% of total assets.
How many people work at Synapharm Industrial Synthesis?
1.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Synapharm Industrial Synthesis?
The register lists 7 active mandates at Synapharm Industrial Synthesis. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Synapharm Industrial Synthesis
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →